Cargando…
How COVID-19 interacts with interstitial lung disease
The global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had far-reaching impacts on patients with interstitial lung disease (ILD), from diagnosis to management. In addition, after infection, persistent parenchymal change is associated with ongoing symptoms and...
Autores principales: | Myall, Katherine J., Martinovic, Jennifer L., West, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908865/ https://www.ncbi.nlm.nih.gov/pubmed/35284020 http://dx.doi.org/10.1183/20734735.0158-2021 |
Ejemplares similares
-
Persistent Post–COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment
por: Myall, Katherine Jane, et al.
Publicado: (2021) -
The burden of progressive fibrotic interstitial lung disease across the UK
por: Simpson, Thomas, et al.
Publicado: (2021) -
Cellular interactions in the pathogenesis of interstitial lung diseases
por: Bagnato, Gianluca, et al.
Publicado: (2015) -
Pulmonary Sequelae of COVID-19: Focus on Interstitial Lung Disease
por: Johnston, Janet, et al.
Publicado: (2023) -
Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them?
por: Sambataro, Domenico, et al.
Publicado: (2020)